ARCHIVES

Ivax Paclitaxel To Remain On Market In Deal With BMS.

This article is from The Cancer Letter archive.

Vol. 28 No. 05 | February 1, 2002

Download PDF Visit The Full Archive

Related Articles

ASCO Foundation Raised $200,000 In Its First Year.

June 2, 2000

LAK/IL-2 Extramural Trials Expanded to 20 More cancers

January 8, 1988

Hybridoma Cell Lines Available from NCI

September 3, 1982

NCAB, Hammer Agree On how 41 Billion To Be Handled: No String Attached

October 14, 1988

Litton’s Government Contracts Status Under Review

September 6, 1985

New Task Force For Nutrition Research Urged By NCAB Committee

February 19, 1982